Effect of rosuvastatin on outcomes in chronic haemodialysis patients – design and rationale of the AURORA study

doi:10.1186/1468-6708-6-9

Current Controlled Trials in Cardiovascular Medicine

Volume 6

Viewing options:

Abstract
Full text
PDF (400KB)
Additional files

Associated material:

Related literature:

Articles citing this article
on BioMed Central
on Google Scholar
on ISI Web of Science
on PubMed Central
Other articles by authors
on Google Scholar

Fellström B
Zannad F
Schmieder R
Holdaas H
Jardine A
Rose H
Wilpshaar W

on PubMed

Fellström B
Zannad F
Schmieder R
Holdaas H
Jardine A
Rose H
Wilpshaar W
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Research

Effect of rosuvastatin on outcomes in chronic haemodialysis patients – design and rationale of the AURORA study

Bengt Fellström¹ , Faiez Zannad² , Roland Schmieder³ , Hallvard Holdaas⁴ , Alan Jardine⁵ , Helen Rose⁶ and Wim Wilpshaar⁷ for the AURORA Study Group

¹Department of Medical Science, Renal Unit, University Hospital, Uppsala, Sweden

²Clinical Investigation Center INSERM (CIC), Hôpital Jeanne d'Arc, Toul, France

³Med Klinik IV, Univ.-Klinik Erlangen-Nürnberg, Germany

⁴Department of Nephrology, Rikshospitalet, Oslo, Norway

⁵Department of Medicine and Therapeutics, Western Infirmary Hospital, Glasgow, United Kingdom

⁶AstraZeneca, Macclesfield, United Kingdom

⁷AstraZeneca, Macclesfield, United Kingdom

author email corresponding author email

Current Controlled Trials in Cardiovascular Medicine 2005, 6:9doi:10.1186/1468-6708-6-9


Published:	23 May 2005

Additional files

Additional File 1:

Table 2. study plan (includes table footnotes)

Format: PDF Size: 57KB Download file

This file can be viewed with: Adobe Acrobat Reader